ETON — Eton Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.43bn
- $1.43bn
- $79.95m
Brief: Eton Pharmaceuticals Q3 Net Income USD -1.927 Million
Eton Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Eton Pharmaceuticals Q2 Net Income USD -2.585 Million
Eton Pharmaceuticals Inc expected to post a loss of 4 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-BTCS, BrainStorm Cell, Moderna
U.S. STOCKS ON THE MOVE- Moderna, BrainStorm Cell, General Dynamics
U.S. STOCKS ON THE MOVE-ProKidney, Eton Pharma, Datadog
Eton Pharma rises after US FDA accepts application for hormone disorder drug
Brief: Eton Pharmaceuticals Announces FDA Acceptance Of New Drug Application For Et-600
Eton Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Eton Pharmaceuticals Q1 Net Income USD -1.572 Million
Eton Pharmaceuticals Inc expected to post earnings of 5 cents a share - Earnings Preview
Eton Pharmaceuticals Inc expected to post earnings of 2 cents a share - Earnings Preview
Brief: Eton Pharmaceuticals Says FDA Review Expected To Take 10 Months, Potential Q1 2026 Launch
U.S. STOCKS ON THE MOVE-Shake Shack, SatixFy, Enova
U.S. STOCKS ON THE MOVE-Shake Shack, SatixFy, Enova
Eton Pharma falls after co licenses rare disease drug to Spanish company
Brief: Eton Pharmaceuticals Inc - Esteve To Pay Eur4 Million Up Front For Increlex Rights - SEC Filing
Brief: ESTEVE Signs License & Supply Agreement With Eton Pharmaceuticals With Global Rights For Increlex, Except For USA